PANGeA - Physical Activity and Nutrition for Quality Ageing

计划入组 950 人 · 首次发布于 2021 年 5 月 24 日

PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression

计划入组 80 人 · 首次发布于 2014 年 8 月 11 日

FoodImage 3 Laboratory

计划入组 25 人 · 首次发布于 2023 年 9 月 11 日

LLC-0424

IB-RA (Innobioscience LLC)

Gln28Exenatide(Prolynx LLC)

Pangea Pharmaceuticals, LLC

United States

ENDOCRINOLOGY LABORATORY

United States

AKHAVI LABORATORY

Iran

Genetic Analysis Launches GA-map MHI GutHealth Diagnostic Kit for Recurrent C. difficile Infection

Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues

MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases